The VAS scores in the RFA group at 1 and 3 months after treatment were significantly lower than those in the RF group before treatment (1.8 ± 1.5 vs. 2.6 ± 1.4, 1.6 ± 1.1 vs. 2.8 ± 1.2), (P all
The VAS score was significantly lower than before the TREATMENT of RF Group 1 and 3 months after treatment in RFA group (1.8 x 1.5 to 2.6 to 1.4, 1.6 to 1.1 to 2.8 to 1.2), (P